Frequency of thromboembolic events in patients with lung cancer at the time of diagnosis and in the course of disease

M. Samulowski, C. Crolow, T. Blum, J. Kollmeier, W. Grüning, N. Schönfeld, R. C. Bittner, T. T. Bauer (Berlin, Germany)

Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Session: Palliation and morbidity in lung cancer patients
Session type: Thematic Poster Session
Number: 2769
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Samulowski, C. Crolow, T. Blum, J. Kollmeier, W. Grüning, N. Schönfeld, R. C. Bittner, T. T. Bauer (Berlin, Germany). Frequency of thromboembolic events in patients with lung cancer at the time of diagnosis and in the course of disease. Eur Respir J 2011; 38: Suppl. 55, 2769

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The incidence of serious venous thromboembolic events in 1157 lung cancer patients
Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology
Year: 2008

Venous thromboembolic disease in patients with small cell lung cancer: incidence and clinicopathological risk factors
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020


Post-surgery complications in patients with chronic lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 735s
Year: 2006

Different mortality, recurrence and bleeding between cancer and non cancer patients with pulmonary embolism (PE): 1 year follow-up.
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017

Factors affecting the duration from diagnosis to treatment in patients with lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 668s
Year: 2007

Incidence and outcome of lung cancer in patients with chronic respiratory failure
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019

Time to move from prognostication to diagnosis and treatment of heart disease in acute exacerbation of COPD
Source: Eur Respir J, 49 (6) 1700912; 10.1183/13993003.00912-2017
Year: 2017



The comparison of sarcoidosis patients with benign and recurrent clinical course of the disease
Source: Eur Respir J 2005; 26: Suppl. 49, 331s
Year: 2005

Does d-dimer level predict pulmonary thromboembolism diagnosis in patients with lung cancer?
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019


Distribution of severity of patients with obstructive lung disease in an at risk population
Source: Eur Respir J 2004; 24: Suppl. 48, 474s
Year: 2004

Predictors of major serious manifestations in the terminal stage of lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Long-term risks of cardiovascular events in patients with chronic kidney disease who survived sepsis
Source: International Congress 2016 – Sepsis and ARDS: looking forward
Year: 2016


Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Adverse events of surgical lung biopsy in patients with interstitial lung disease
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009


Managing the initial treatment and multiple relapses in a small cell lung cancer patient with limited disease
Source: International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care
Year: 2018


Influence of lung infection on the course and outcome in patients with stroke
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012

Pulmonary diseases in prisoner patients. A one year experience of the modes of diagnosis, incidence and reccurence of pulmonary diseases and their correlation with other diseases appearing in this diverse population
Source: Eur Respir J 2006; 28: Suppl. 50, 700s
Year: 2006

Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018


The analysis of lung cancer patients (LCP) survival during one-year period after diagnosing of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 88s
Year: 2006

Subsequent COPD and lung cancer in patients with autoimmune disease
Source: Eur Respir J 2011; 37: 463
Year: 2011